ATE468139T1 - Photoreaktive verbindung mit spezifischer bindung an calciumbindende proteine - Google Patents

Photoreaktive verbindung mit spezifischer bindung an calciumbindende proteine

Info

Publication number
ATE468139T1
ATE468139T1 AT05703240T AT05703240T ATE468139T1 AT E468139 T1 ATE468139 T1 AT E468139T1 AT 05703240 T AT05703240 T AT 05703240T AT 05703240 T AT05703240 T AT 05703240T AT E468139 T1 ATE468139 T1 AT E468139T1
Authority
AT
Austria
Prior art keywords
binding
binding proteins
calcium
reagent
photoreactive compound
Prior art date
Application number
AT05703240T
Other languages
English (en)
Inventor
Varda Shoshan-Barmatz
Adrian Israelson
Original Assignee
Varda Shoshan-Barmatz
Adrian Israelson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Varda Shoshan-Barmatz, Adrian Israelson filed Critical Varda Shoshan-Barmatz
Application granted granted Critical
Publication of ATE468139T1 publication Critical patent/ATE468139T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4728—Calcium binding proteins, e.g. calmodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin
AT05703240T 2004-02-19 2005-02-17 Photoreaktive verbindung mit spezifischer bindung an calciumbindende proteine ATE468139T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL16049204A IL160492A0 (en) 2004-02-19 2004-02-19 Photoreactive compound specifically binding to calcium binding proteins
PCT/IL2005/000203 WO2005079155A2 (en) 2004-02-19 2005-02-17 Photoreactive compound specifically binding to calcium binding proteins

Publications (1)

Publication Number Publication Date
ATE468139T1 true ATE468139T1 (de) 2010-06-15

Family

ID=34073868

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05703240T ATE468139T1 (de) 2004-02-19 2005-02-17 Photoreaktive verbindung mit spezifischer bindung an calciumbindende proteine

Country Status (7)

Country Link
US (1) US8034314B2 (de)
EP (1) EP1722818B1 (de)
AT (1) ATE468139T1 (de)
CA (1) CA2556054A1 (de)
DE (1) DE602005021322D1 (de)
IL (1) IL160492A0 (de)
WO (1) WO2005079155A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL178494A0 (en) * 2006-10-05 2007-02-11 Univ Ben Gurion Fluorescent ruthenium compounds for detecting calcium binding proteins
KR101151800B1 (ko) 2009-02-04 2012-06-01 국민대학교산학협력단 칼슘 이온 검출용 센서
US20170362173A1 (en) * 2014-12-15 2017-12-21 The Regents Of The University Of California Anti-arrhythmicity agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888248A (en) 1986-07-01 1989-12-19 Hidefumi Hirai Colloidal metal dispersion, and a colloidal metal complex
DE19712530A1 (de) * 1997-03-25 1998-10-01 Boehringer Mannheim Gmbh Neue Monomerbausteine zur Markierung von peptidischen Nukleinsäuren
US20030144570A1 (en) 1999-11-12 2003-07-31 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors
US6388001B1 (en) 1999-12-21 2002-05-14 General Electric Company Compounding filled silicone compositions

Also Published As

Publication number Publication date
EP1722818A2 (de) 2006-11-22
US20070298120A1 (en) 2007-12-27
WO2005079155A2 (en) 2005-09-01
EP1722818A4 (de) 2008-08-13
US8034314B2 (en) 2011-10-11
IL160492A0 (en) 2004-07-25
EP1722818B1 (de) 2010-05-19
DE602005021322D1 (de) 2010-07-01
CA2556054A1 (en) 2005-09-01
WO2005079155A3 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
CY1124802T1 (el) Δεσμευτικοι παραγοντες σκληροστινης
TN2009000323A1 (en) Modulators of sclerostin binding partners for treating bone-related disorders
CY1119412T1 (el) Μεθοδοι για την αξιολογηση μιας ανοσοαποκρισης σε εναν θεραπευτικο παραγοντα
MX2007008017A (es) Polipeptidos que se ligan a br3 y usos de los mismos.
TR201910348T4 (tr) Matriks metalloproteinaz 9 için antikorlar.
MX2007002908A (es) Sondas inmovilizadas y metodos para detectar proteinas prionicas alteradas conformacionalmente.
EA200801621A1 (ru) Антитела, направленные на her-3, и их применение
WO2005035551A3 (en) Inhibitors of proteins that bind phosphorylated molecules
UA94576C2 (ru) Выделенное антитело, которое связывается с igf-1r, композиция, которая его содержит, и способы, которые касаются антител
AU2006205900A8 (en) Methods and assays for distinguishing between different forms of diseases and disorders characterized by thrombocytopenia and/or by spontaneous interaction between Von Willebrand Factor (vWF) and platelets
ATE504602T1 (de) Für humane matriptase spezifische bindungsproteine
MA30153B1 (fr) Anticorps anti-ox40l et methodes correspondantes
UA102867C2 (uk) Антитіла до cxcr4 та їх застосування у лікуванні раку
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
EA200701452A1 (ru) Моноклональные антитела против подобного ангиопоэтину белка 4 (angptl 4)
DE602006007967D1 (de) Gegen das gemeinsame epitop von mutierten p53 gerichtete humane synthetische einzelkettenantikörper und anwendungen davon
WO2006053315A3 (en) Methods and compositions for treating cellular proliferative diseases
WO2008034016A3 (en) Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins
MX2010004615A (es) Anticuerpos monoclonales contra proteina c. activada e inactivada.
WO2004029072A3 (en) PrPsc -INTERACTING MOLECULES AND USES THEREOF
WO2008008224A3 (en) Sour taste receptor compositions and methods
ATE468139T1 (de) Photoreaktive verbindung mit spezifischer bindung an calciumbindende proteine
ATE527285T1 (de) Anti-muc1-alpha-beta-antikörper
DK2005190T3 (da) Inhibering af gasc1
WO2006108051A3 (en) Compositions and methods relating to alzheimer's disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties